Celecoxib
- Product NDC
- 27808-296
- 11-digit product format
- 278080296
- Labeler code
- 27808
- Product ID
- 27808-296_2144dfb3-f0a5-4cb7-8957-1481c2ec28fb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Celecoxib
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Cranbury Pharmaceuticals, LLC
- Application
- ANDA210071
- Marketing category
- ANDA
- Marketing start
- 2024-12-01
- Substance
- CELECOXIB
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Celecoxib
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CELECOXIB | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | JCX84Q7J1L |
| Rxcui | 205322, 205323, 686379 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 27808-296-01 | Celecoxib | 100 in 1 BOTTLE | CAPSULE | 100 | | 5 |
| 27808-296-02 | Celecoxib | 500 in 1 BOTTLE | CAPSULE | 500 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 27808-296 | CELECOXIB CAPSULE [CRANBURY PHARMACEUTICALS, LLC] | 5 | Current NDC, 2 package rows | 20250210_933532fa-044a-48b1-bbe4-28062564f98a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 27808-296-01 | 27808029601 | 100 CAPSULE in 1 BOTTLE (27808-296-01) | 100 capsule | 2024-12-01 | No | No | Current |
| 27808-296-02 | 27808029602 | 500 CAPSULE in 1 BOTTLE (27808-296-02) | 500 capsule | 2024-12-01 | No | No | Current |